Future treatments for beta-thalassemia will depend on the benefit/risk/cost ratios for conventional transfusion and iron chelation [70], γ-globin induction [186], allogeneic bone marrow transplantation [187] and gene therapy [170], and the availability of these treatments in the low-income countries
